EarningsQ4 2021 Earnings Report

Sino Biopharmaceutical (SBMFF) Q4 2021 Earnings Report

44 Followers

SBMFF Q4 2021 EPS Results

Actual EPS$0.01

Consensus EPS$0.12

Beat/MissMissed by -$0.10

One Year Ago EPS<$0.01

Actual Revenue―

Expected Revenue$6.19B

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2021

Date03/31/2022

TimeTBA

Conference CallThursday, March 31, 2022

SBMFF Upcoming Earnings

Sino Biopharmaceutical's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Apr 01, 2027	2026 (Q4)	0.01 / -	0.001	―
Aug 19, 2026	2026 (Q2)	0.02 / 0.03	0.028	1.06% (<+0.01)
Mar 26, 2026	2025 (Q4)	<0.01 / <0.01	0.004	-66.67% (>-0.01)
Aug 18, 2025	2025 (Q2)	0.02 / 0.03	0.011	144.16% (+0.02)
Mar 20, 2025	2024 (Q4)	0.01 / <0.01	0.007	-33.33% (>-0.01)
Aug 13, 2024	2024 (Q2)	0.01 / 0.01	0.012	-3.75% (>-0.01)
Mar 28, 2024	2023 (Q4)	0.01 / <0.01	0.004	50.00% (<+0.01)
Aug 25, 2023	2023 (Q2)	0.01 / 0.01	0.014	-13.04% (>-0.01)
May 24, 2023	2023 (Q1)	- / -	―	―
Mar 31, 2023	2022 (Q4)	0.01 / <0.01	0.01	-57.14% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed